Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 43

1.

Acute rheumatic fever prophylaxis in high-income countries: clinical observations from an Italian multicentre, retrospective study.

Taddio A, Pillon R, Pastore S, Monasta L, Tommasini A, Di Battista C, Mascheroni E, Berton E, Maggio MC, Simonini G, Breda L, Cimaz R, Pires Marafon D, Meli L, Bracaglia C, De Benedetti F, Ventura A; Italian Paediatric Rheumatology Study Group.

Clin Exp Rheumatol. 2020 Jan 20. [Epub ahead of print]

PMID:
31969217
2.

The interferon-gamma pathway is selectively up-regulated in the liver of patients with secondary hemophagocytic lymphohistiocytosis.

Prencipe G, Bracaglia C, Caiello I, Pascarella A, Francalanci P, Pardeo M, Meneghel A, Martini G, Rossi MN, Insalaco A, Marucci G, Nobili V, Spada M, Zulian F, De Benedetti F.

PLoS One. 2019 Dec 17;14(12):e0226043. doi: 10.1371/journal.pone.0226043. eCollection 2019.

3.

A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function.

Lam MT, Coppola S, Krumbach OHF, Prencipe G, Insalaco A, Cifaldi C, Brigida I, Zara E, Scala S, Di Cesare S, Martinelli S, Di Rocco M, Pascarella A, Niceta M, Pantaleoni F, Ciolfi A, Netter P, Carisey AF, Diehl M, Akbarzadeh M, Conti F, Merli P, Pastore A, Levi Mortera S, Camerini S, Farina L, Buchholzer M, Pannone L, Cao TN, Coban-Akdemir ZH, Jhangiani SN, Muzny DM, Gibbs RA, Basso-Ricci L, Chiriaco M, Dvorsky R, Putignani L, Carsetti R, Janning P, Stray-Pedersen A, Erichsen HC, Horne A, Bryceson YT, Torralba-Raga L, Ramme K, Rosti V, Bracaglia C, Messia V, Palma P, Finocchi A, Locatelli F, Chinn IK, Lupski JR, Mace EM, Cancrini C, Aiuti A, Ahmadian MR, Orange JS, De Benedetti F, Tartaglia M.

J Exp Med. 2019 Dec 2;216(12):2778-2799. doi: 10.1084/jem.20190147. Epub 2019 Oct 10.

PMID:
31601675
4.

A patient with stimulator of interferon genes-associated vasculopathy with onset in infancy without skin vasculopathy.

Raffaele CGL, Messia V, Moneta G, Caiello I, Federici S, Pardeo M, Bracaglia C, De Benedetti F, Insalaco A.

Rheumatology (Oxford). 2020 Apr 1;59(4):905-907. doi: 10.1093/rheumatology/kez444. No abstract available.

PMID:
31598716
5.

Interleukin-18 in pediatric rheumatic diseases.

Prencipe G, Bracaglia C, De Benedetti F.

Curr Opin Rheumatol. 2019 Sep;31(5):421-427. doi: 10.1097/BOR.0000000000000634.

PMID:
31192813
6.

An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.

Arduini A, Marasco E, Marucci G, Pardeo M, Insalaco A, Caiello I, Moneta GM, Prencipe G, De Benedetti F, Bracaglia C.

Pediatr Rheumatol Online J. 2019 May 22;17(1):25. doi: 10.1186/s12969-019-0328-3.

7.

Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis.

Sota J, Insalaco A, Cimaz R, Alessio M, Cattalini M, Gallizzi R, Maggio MC, Lopalco G, La Torre F, Fabiani C, Pardeo M, Olivieri AN, Sfriso P, Salvarani C, Gaggiano C, Grosso S, Bracaglia C, De Benedetti F, Rigante D, Cantarini L.

Front Pharmacol. 2019 Jan 8;9:1526. doi: 10.3389/fphar.2018.01526. eCollection 2018.

8.

Variable Clinical Phenotypes and Relation of Interferon Signature with Disease Activity in ADA2 Deficiency.

Insalaco A, Moneta GM, Pardeo M, Caiello I, Messia V, Bracaglia C, Passarelli C, De Benedetti F.

J Rheumatol. 2019 May;46(5):523-526. doi: 10.3899/jrheum.180045. Epub 2019 Jan 15.

PMID:
30647181
9.

Systemic juvenile idiopathic arthritis: New insights into pathogenesis and cytokine directed therapies.

Pardeo M, Bracaglia C, De Benedetti F.

Best Pract Res Clin Rheumatol. 2017 Aug;31(4):505-516. doi: 10.1016/j.berh.2018.02.002. Epub 2018 Mar 21. Review.

PMID:
29773270
10.

Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic Arthritis.

Cecchin V, Zannin ME, Ferrari D, Pontikaki I, Miserocchi E, Paroli MP, Bracaglia C, Marafon DP, Pastore S, Parentin F, Simonini G, De Libero C, Falcini F, Petaccia A, Filocamo G, De Marco R, La Torre F, Guerriero S, Martino S, Comacchio F, Muratore V, Martini G, Vittadello F, Zulian F.

J Rheumatol. 2018 Aug;45(8):1167-1172. doi: 10.3899/jrheum.171006. Epub 2018 Apr 15.

11.

Neutralization of IFN-γ reverts clinical and laboratory features in a mouse model of macrophage activation syndrome.

Prencipe G, Caiello I, Pascarella A, Grom AA, Bracaglia C, Chatel L, Ferlin WG, Marasco E, Strippoli R, de Min C, De Benedetti F.

J Allergy Clin Immunol. 2018 Apr;141(4):1439-1449. doi: 10.1016/j.jaci.2017.07.021. Epub 2017 Aug 12.

PMID:
28807602
12.

ANCA-associated vasculitis in childhood: recent advances.

Calatroni M, Oliva E, Gianfreda D, Gregorini G, Allinovi M, Ramirez GA, Bozzolo EP, Monti S, Bracaglia C, Marucci G, Bodria M, Sinico RA, Pieruzzi F, Moroni G, Pastore S, Emmi G, Esposito P, Catanoso M, Barbano G, Bonanni A, Vaglio A.

Ital J Pediatr. 2017 May 5;43(1):46. doi: 10.1186/s13052-017-0364-x. Review.

13.

Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis.

Simonini G, Bracaglia C, Cattalini M, Taddio A, Brambilla A, De Libero C, Pires Marafon D, Caputo R, Cimaz R.

J Rheumatol. 2017 Jun;44(6):822-826. doi: 10.3899/jrheum.161336. Epub 2017 Apr 1.

PMID:
28365583
14.

Macrophage Activation Syndrome: different mechanisms leading to a one clinical syndrome.

Bracaglia C, Prencipe G, De Benedetti F.

Pediatr Rheumatol Online J. 2017 Jan 17;15(1):5. doi: 10.1186/s12969-016-0130-4. Review.

15.

Use of a mouse model to identify a blood biomarker for IFNγ activity in pediatric secondary hemophagocytic lymphohistiocytosis.

Buatois V, Chatel L, Cons L, Lory S, Richard F, Guilhot F, Johnson Z, Bracaglia C, De Benedetti F, de Min C, Kosco-Vilbois MH, Ferlin WG.

Transl Res. 2017 Feb;180:37-52.e2. doi: 10.1016/j.trsl.2016.07.023. Epub 2016 Aug 4.

PMID:
27559680
16.

Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

Bracaglia C, de Graaf K, Pires Marafon D, Guilhot F, Ferlin W, Prencipe G, Caiello I, Davì S, Schulert G, Ravelli A, Grom AA, de Min C, De Benedetti F.

Ann Rheum Dis. 2017 Jan;76(1):166-172. doi: 10.1136/annrheumdis-2015-209020. Epub 2016 Jun 13.

PMID:
27296321
17.

Herpes Virus Infections During Treatment With Etanercept in Juvenile Idiopathic Arthritis.

Nicolai R, Cortis E, Ravà L, Bracaglia C, Pardeo M, Insalaco A, Buonuomo PS, Tozzi AE, De Benedetti F.

J Pediatric Infect Dis Soc. 2016 Mar;5(1):76-9. doi: 10.1093/jpids/piu078. Epub 2014 Jul 31.

PMID:
26908493
18.

A Heterozygous RAB27A Mutation Associated with Delayed Cytolytic Granule Polarization and Hemophagocytic Lymphohistiocytosis.

Zhang M, Bracaglia C, Prencipe G, Bemrich-Stolz CJ, Beukelman T, Dimmitt RA, Chatham WW, Zhang K, Li H, Walter MR, De Benedetti F, Grom AA, Cron RQ.

J Immunol. 2016 Mar 15;196(6):2492-503. doi: 10.4049/jimmunol.1501284. Epub 2016 Feb 15.

19.

Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial.

Ruperto N, Pistorio A, Oliveira S, Zulian F, Cuttica R, Ravelli A, Fischbach M, Magnusson B, Sterba G, Avcin T, Brochard K, Corona F, Dressler F, Gerloni V, Apaz MT, Bracaglia C, Cespedes-Cruz A, Cimaz R, Couillault G, Joos R, Quartier P, Russo R, Tardieu M, Wulffraat N, Bica B, Dolezalova P, Ferriani V, Flato B, Bernard-Medina AG, Herlin T, Trachana M, Meini A, Allain-Launay E, Pilkington C, Vargova V, Wouters C, Angioloni S, Martini A; Paediatric Rheumatology International Trials Organisation (PRINTO).

Lancet. 2016 Feb 13;387(10019):671-8. doi: 10.1016/S0140-6736(15)01021-1. Epub 2015 Nov 30.

PMID:
26645190
20.

Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome.

Cifaldi L, Prencipe G, Caiello I, Bracaglia C, Locatelli F, De Benedetti F, Strippoli R.

Arthritis Rheumatol. 2015 Nov;67(11):3037-46. doi: 10.1002/art.39295.

Supplemental Content

Loading ...
Support Center